Steve Goldstein to Selective Estrogen Receptor Modulators
This is a "connection" page, showing publications Steve Goldstein has written about Selective Estrogen Receptor Modulators.
Connection Strength
0.032
-
Endometrial safety of ospemifene: results of the phase 2/3 clinical development program. Menopause. 2015 Jan; 22(1):36-43.
Score: 0.032
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.